Neoadjuvant everolimus plus letrozole versus fluorouracil, epirubicin and cyclophosphamide for ER-positive, HER2-negative breast cancer: a randomized pilot trial
Wei Wu(Sun Yat-sen University), Jieqiong Liu(Sun Yat-sen University), Yan Nie(Sun Yat-sen University), Jiewen Chen(Center for Excellence in Molecular Cell Science), Yandan Yao(Sun Yat-sen University), Zhanghai He(Sun Yat-sen University), Fengxi Su(Sun Yat-sen University), Liang Jin(Kunming Medical University), Nanyan Rao(Sun Yat-sen University), Heran Deng(Sun Yat-sen University), Yaping Yang(Sun Yat-sen University)
Cited by 14
Related Papers
The HIF-1α antisense long non-coding RNA drives a positive feedback loop of HIF-1α mediated transactivation and glycolysis
|Nature Communications|2021|196
Rac1 activates non-oxidative pentose phosphate pathway to induce chemoresistance of breast cancer
|Nature Communications|2020|187
Breast Phyllodes Tumors Recruit and Repolarize Tumor-Associated Macrophages via Secreting CCL5 to Promote Malignant Progression, Which Can Be Inhibited by CCR5 Inhibition Therapy
|Clinical Cancer Research|2019|166
Fusobacterium and Colorectal Cancer
|Frontiers in Oncology|2018|134
LncRNA NKILA suppresses TGF‐β‐induced epithelial–mesenchymal transition by blocking NF‐κB signaling in breast cancer
|International Journal of Cancer|2018|129